iiCON is designed to facilitate, nurture, and accelerate innovation.
Our goal is to revitalise the global pipeline of new drugs, diagnostics, vaccines, and preventative products for infectious diseases.
We remove barriers to market by providing companies access to world-leading research expertise, market intelligence, and cutting-edge facilities. This helps companies progress pioneering treatments and products to market more quickly, safely, and affordably.
We work with companies of all sizes, at all stages of the innovation journey – from very early-stage conceptual work, through to clinical trials, manufacturing, and market positioning.
The consortium proactively identifies and engages with the most innovative companies working in the sector globally.
We forge long-term collaborative relationships with these organisations and facilitate impactful partnerships. This accelerates and enables innovative research and product development – fast-tracking the next generation of game-changing new products to patients and communities.
Companies can access our ten specialist research platforms – which provide world-leading expertise at every stage of the innovation journey, from conception to adoption.
Read our case studies to see how we’ve partnered with companies from early-stage start-ups to global pharma leaders to support their innovation and fast track new products and treatments to patients and communities.
If you’re interested in working with our specialist research partners to progress a product or treatment, or if you’d like to learn more about how we work – please get in touch with our dedicated Business Development team to find out more.